FilingReader Intelligence
Livzon Pharmaceutical repurchases shares, cancels stock options
August 20, 2025 at 05:18 PM UTC•By FilingReader AI
Livzon Pharmaceutical Group repurchased 93,300 H-shares for RMB 3.8 million on August 20, 2025.
The board approved cancelling 2022 stock options in April due to unmet performance targets. The company reported total assets of RMB 24.2 billion and operating income of RMB 6.3 billion in its semi-annual results.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
SZSE:000513•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Livzon Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime